Baseline Study on Treatment of Parotid Tumor in a Tertiary Care Hospital, Dhaka
DOI:
https://doi.org/10.3329/bjo.v31i2.88995Keywords:
Parotid Gland, Clinicopathological Pattern, Pleomorphic adenoma, Facial nerveAbstract
Introduction: Parotid gland tumors are a diverse group of salivary gland neoplasms with varying clinical, histopathological, and therapeutic outcomes. They represent the most common site for salivary gland tumors, encompassing both benign and malignant
types.This study aimed to assess the clinicopathological patterns and treatment outcomes of parotid gland tumors.
Methods: This was a prospective study conducted at the Department of Otolaryngology- Head & Neck Surgery, Bangabandhu Sheikh Mujib Medical University, Dhaka, on the clinicopathological patterns, treatment outcomes, and complications of parotid gland tumors. A total of 114 patients diagnosed with parotid gland tumors and treated from January 2021 to December 2023 were included. Statistical Package for Social Sciences (SPSS) version 22.0.
Result: The highest incidence in the 21–40 age group (35.08%) and a slight female predominance (M:F ratio 1:1.1). Benign tumors accounted for 59 % of cases, with pleomorphic adenoma being most common (45.5%), while malignant tumors comprised
40.9%, led by mucoepidermoid carcinoma (18.2%). Painless swelling was the most frequent clinical feature (63.6%), predominantly seen in benign tumors, whereas malignancies often presented with painful swelling (25.5%), facial nerve weakness
(4.6%), and skin fixation or lymphadenopathy. Surgical resection alone had a 77.3% success rate. Common complications included seroma (16.4%) and facial nerve injury (15.5%), with recurrence noted only in malignant cases (5.5%).
Conclusion: Surgical resection in benign tumours and surgical resection combined with adjuvant therapy in malignant parotid tumours provided favourable outcome, although complications such as facial nerve injury and seroma were noted. These
findings underline the importance of early diagnosis, appropriate surgical intervention, and the role of adjuvant therapies in managing malignant parotid tumors.
Bangladesh J Otorhinolaryngol 2025; 31(2): 69-76
Downloads
18
12
Downloads
Published
How to Cite
Issue
Section
License
Manuscripts submitted for publication in the Bangladesh Journal of Otorhinolaryngology must not have been previously submitted or published. Accepted papers become the permanent property of the Bangladesh Journal of Otorhinolaryngology. By submitting a manuscript, the authors(s) agree that copyrights for their articles are automatically transferred to Bangladesh Journal of Otorhinolaryngology, if and when the articles are accepted for publication.
The use, in this journal, of registered trade names, trade marks, etc. without special acknowledgement does not imply that such names, as defined by the relevant protection laws, be regarded as unprotected, and, thus, free for general use.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
